Call Options Transactions Made in Q4 2024 in Moon Lake Immunotherapeutics (MLTX)
This table provides information about the institutional ownership of Moon Lake Immunotherapeutics (MLTX) during Q4 2024. The information is specifically focused on institutions that hold call options of MoonLake Immunotherapeutics.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
30.1K+ 162.7% |
$1.38M - $1.74M
|
48.6K
$1.95M
|
|
|
Feb 12, 2025
Q4 2024
|
Citigroup Inc
|
BUY
|
CALL |
25KNew |
$1.15M - $1.45M
|
25K
$1M
|
|
|
Feb 14, 2025
Q4 2024
|
Squarepoint Ops LLC
New York, NY |
BUY
|
CALL |
13KNew |
$596K - $753K
|
13K
$522K
|
|
|
Feb 14, 2025
Q4 2024
|
Jane Street Group, LLC
New York, NY |
BUY
|
CALL |
12.1KNew |
$555K - $701K
|
12.1K
$485K
|
|
|
Feb 14, 2025
Q4 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
CALL |
10KNew |
$458K - $579K
|
10K
$401K
|
|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-1.7K- 12.88% |
$77.9K - $98.4K
|
11.5K
$461K
|
|
|
Feb 13, 2025
Q4 2024
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
CALL |
-2.2K- 73.33% |
$101K - $127K
|
800
$32.1K
|